Tumor lysis syndrome classification

Tumor lysis syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Tumor lysis syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Tumor lysis syndrome classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tumor lysis syndrome classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tumor lysis syndrome classification
CDC on Tumor lysis syndrome classification
Tumor lysis syndrome classification in the news
Blogs on Tumor lysis syndrome classification
Directions to Hospitals Treating Tumor lysis syndrome
Risk calculators and risk factors for Tumor lysis syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Tumor lysis syndrome (TLS) may be classified according to the 1993 Hande-Garrow classification system into two groups: laboratory tumor lysis syndrome (LTLS) and clinical tumor lysis syndrome (CTLS).

Classification

Tumor lysis syndrome may be classified according to the 1993 Hande-Garrow classification system into two groups:

• Laboratory tumor lysis syndrome: patients have positive laboratory findings with no signs or symptoms
• Clinical tumor lysis syndrome: patients have life threatening medical signs and require urgent medical interventions